HAVIV ASI;TEVA PHARMACEUTICAL INDUSTRIES LTD.;TARCIC NORA;KAYE JOEL;BLAUGRUND ERAN
发明人:
申请号：
IL23355714
公开号：
IL233557D0
申请日:
2014.07.08
申请国别(地区):
IL
年份:
2014
代理人:
摘要：
This application provides for a method of treating a human patient afflicted with anti-TNF&alpha； refractory Crohn's disease, of treating a human patient afflicted with non-fibrostenotic Crohn's disease, and of treating a human patient whose Crohn's disease had not been surgically treated, the method comprising periodically administering to the patient an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the patient. This application also provides for a method of inducing or maintaining clinical remission in a human patient afflicted with Crohn's disease comprising periodically administering to the patient an amount of laquinimod effective to induce or maintain clinical remission in the patient, which amount of laquinimod is less than 0.5 mg/day.
